3 ms·

I believe this might have been the study where 25%(?) of the patients were killed by the treatment. As a result, this is only indicated for the very severe RRMS

I believe this might have been the study where 25%(?) of the patients were killed by the treatment. As a result, this is only indicated for the very severe RRMS (relapsing-remitting, not related to Stallman) cases. I'm sure HN can correct me if I'm wrong, but the point to make is that this isn't a cure.

sago 10y ago
Maybe you can read the article and correct yourself? 1/24 patients died during the trial (no causal link was specified), and the treatment was given to progressive MS patients (PPMS or SPMS).